In addition, biglycan, through interaction with TLR2/4 receptors on the surface of macrophages, promotes inflammation by triggering the synthesis of two cytokines important for cancer progression, TNFα and CCL2 [186,187], and thus enhances tumor growth in many cancer cells [68]. This evidence concerns the gene BGN and cancer.